Pamidronate used to ameliorate post renal transplant bone loss is not associated with increased renal dysfunction.

被引：0
|
作者：
Lee, S [1 ]
Glicklich, D [1 ]
Coco, M [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：695A / 695A
页数：1
相关论文
共 50 条
  • [31] Postmenopausal women with mild to moderate renal dysfunction are at increased risk for bone loss and vertebral fractures
    Yamauchi, M.
    Yamaguchi, I.
    Kaji, H.
    Sugimoto, T.
    BONE, 2009, 44 : S92 - S92
  • [32] HYPERTENSION AND RENAL DYSFUNCTION IN BONE-MARROW TRANSPLANT RECIPIENTS
    KONE, BC
    WHELTON, A
    SANTOS, G
    SARAL, R
    WATSON, AJ
    QUARTERLY JOURNAL OF MEDICINE, 1988, 69 (260): : 985 - 995
  • [33] HBV plus increased ALT associated with renal dysfunction
    Nature Reviews Nephrology, 2012, 8 (10) : 553 - 553
  • [34] Renal dysfunction at 3-months post-liver transplant is not associated with poorer long-term renal function
    Cantarovich, M
    Barkun, J
    Metrakos, P
    Deschenes, M
    Alpert, E
    Wong, P
    Fernandez, M
    Tchervenkov, J
    LIVER TRANSPLANTATION, 2003, 9 (06) : C75 - C75
  • [35] Latent cytomegalovirus infection is associated with increased risk for late graft loss in renal transplant recipients
    van Ree, Rutger M.
    Oterdoom, Leendert H.
    De Vries, Aiko P. J.
    Gansevoort, Ron T.
    van Son, Willem J.
    van der Heide, Jaap J. Homan
    De Jong, Paul E.
    Gans, Reinold O. B.
    Bakker, Stephan J. L.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 84 - 85
  • [36] Bone mineral density before and after renal transplantation: Is uraemic osteodystrophy type influencing the prevention of post transplantation accelerated bone loss by pamidronate?
    Trombetti, Andrea
    Stoermann, Catherine
    Hadaya, Karine
    Pennisi, Piera
    Buehler, Leo H.
    Rizzoli, Rene
    Martin, Pierre-Yves
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 413 - 413
  • [37] Aprotinin associated with increased renal dysfunction, but not with increased cerebrovascular or cardiovascular events
    不详
    FORMULARY, 2007, 42 (07) : 441 - 442
  • [38] Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant
    Torregrosa, J. -V.
    Fuster, D.
    Monegal, A.
    Gentil, M. A.
    Bravo, J.
    Guirado, L.
    Muxi, A.
    Cubero, J.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (01) : 281 - 287
  • [39] Alendronate prevents further bone loss in renal transplant recipients
    Giannini, S
    D'Angelo, A
    Carraro, G
    Nobile, M
    Rigotti, P
    Bonfante, L
    Marchini, F
    Zaninotto, M
    Carbonare, LD
    Sartori, L
    Crepaldi, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (11) : 2111 - 2117
  • [40] Bone mineral density before and after renal transplantation: Is uraemic osteodystrophy type influencing the prevention of post transplantation accelerated bone loss by pamidronate?
    Trombetti, Andrea
    Stoermann, Catherine
    Hadaya, Karine
    Pennisi, Piera
    Buehler, Leo H.
    Rizzoli, Rene
    Martin, Pierre-Yves
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 413 - 413
12345